Protagonist Therapeutics Inc (PTGX)
45.31
+3.66
(+8.79%)
USD |
NASDAQ |
Nov 22, 14:24
Protagonist Therapeutics Shareholders Equity (Quarterly): 531.92M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 531.92M |
| June 30, 2024 | 541.32M |
| March 31, 2024 | 560.44M |
| December 31, 2023 | 336.68M |
| September 30, 2023 | 302.15M |
| June 30, 2023 | 294.07M |
| March 31, 2023 | 216.17M |
| December 31, 2022 | 215.61M |
| September 30, 2022 | 243.62M |
| June 30, 2022 | 267.98M |
| March 31, 2022 | 301.78M |
| December 31, 2021 | 300.02M |
| September 30, 2021 | 329.66M |
| June 30, 2021 | 357.45M |
| March 31, 2021 | 259.33M |
| December 31, 2020 | 279.61M |
| September 30, 2020 | 169.59M |
| June 30, 2020 | 167.48M |
| Date | Value |
|---|---|
| March 31, 2020 | 62.67M |
| December 31, 2019 | 79.96M |
| September 30, 2019 | 95.36M |
| June 30, 2019 | 84.32M |
| March 31, 2019 | 100.82M |
| December 31, 2018 | 112.52M |
| September 30, 2018 | 123.96M |
| June 30, 2018 | 107.66M |
| March 31, 2018 | 114.62M |
| December 31, 2017 | 120.63M |
| September 30, 2017 | 57.84M |
| June 30, 2017 | 61.03M |
| March 31, 2017 | 74.89M |
| December 31, 2016 | 87.56M |
| September 30, 2016 | 97.49M |
| June 30, 2016 | 20.41M |
| March 31, 2016 | 26.38M |
| December 31, 2015 | 9.596M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
62.67M
Minimum
Mar 2020
560.44M
Maximum
Mar 2024
290.87M
Average
286.84M
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 70.16B |
| Assembly Biosciences Inc | 26.00M |
| Precision BioSciences Inc | 64.87M |
| Entrada Therapeutics Inc | 422.45M |
| NovaBay Pharmaceuticals Inc | 1.072M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 603.86M |
| Total Liabilities (Quarterly) | 71.94M |
| Current Ratio | 10.70 |